SAN JOSE, CA, April 6, 2013 /PRNewswire/ - The American College of Medical Genetics (ACMG) issued a position statement to support the use of non-invasive
prenatal screening (NIPS) in women with singleton pregnancies. The
statement can be found at this link: http://www.acmg.net/docs/nips-GiM_galley_text_130301.pdf
The statement clearly emphasizes NIPS as a screening, and not
diagnostic, test. It goes on to highlight the advantages of higher
detection rates and lower false positives rates associated with NIPS
versus maternal serum screening, and it underscored the importance of
first trimester ultrasound regardless of screening modality. ACMG
recommends both pre-test and post-test counseling to inform women about
NIPS tests in regards to benefits and limitations. As a screening test,
NIPS can lead to both false positive and false negative results.
NIPS with the Harmony Prenatal Test has been studied in more than 6,000
women to date across multiple studies. Ariosa shares ACMG's view that
NIPS is a safe and effective prenatal testing option for pregnant women
and that it should be responsibly introduced into clinical practice.
"ACMG's statement provides ongoing support of non-invasive prenatal
screening with cell-free DNA as a major clinical advance," said Ken
Song, CEO of Ariosa Diagnostics. "Our commitment to responsible
introduction of this screening technology will help women manage the
health of their pregnancy and fetus.
About Ariosa Diagnostics
Ariosa Diagnostics, Inc. is a molecular diagnostics company committed to
innovating together to improve patient care. The flagship product, the
Harmony Prenatal Test, is a safe, highly accurate and affordable
prenatal test for maternal and fetal health. Led by an experienced
team, Ariosa is using its proprietary technology to perform a directed
analysis of cell-free DNA in blood. The Harmony Prenatal Test equips
pregnant women and their healthcare providers with reliable information
to make decisions regarding their health, without creating unnecessary
stress or anxiety.
The company began operations in 2010 and is headquartered in San Jose,
Calif. For more information, visit www.ariosadx.com. Follow us on Twitter @HarmonyPrenatal and on Facebook at Harmony Prenatal for Healthy Pregnancy.
SOURCE Ariosa Diagnostics, Inc.